Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning

British Journal of Haematology

Volumn 130, Issue 5, 2005, Pages 733-739

  Montero, Aldemar ^a   Savani, Bipin N ^a   Kurlander, Roger ^b   Read, Elizabeth J ^b   Leitman, Susan F ^b   Childs, Richard ^a   Solomon, Scott R ^a   Barrett, A John ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Leukaemia; Stem cell transplantation; T cell chimaerism; T cell depletion

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; VIDARABINE;

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CHIMERA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EVALUATION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE FUNCTION TEST; LEUKEMIA; MALE; PRIORITY JOURNAL; SCHOOL CHILD; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; BLOOD DISEASE; CHILD; FOLLOW UP; HISTOCOMPATIBILITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; MORTALITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CHILD; CYCLOPHOSPHAMIDE; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; VIDARABINE; WHOLE-BODY IRRADIATION;

EID: 27244449486     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05665.x     Document Type: Article

References (23)

1. Antin J.H. Childs R. Filipovich A.H. Giralt S. MacKinnon S. Spitzer T. Weisdorf D. ( 2001) Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 7, 473 485.
2. Bader P. Beck J. Frey A. Schlegel P.G. Hebarth H. Handgretinger R. Einsele H. Niemeyer C. Benda N. Faul C. Kanz L. Niethammer D. Klingebiel T. ( 1998) Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplantation, 21, 487 495.
3. Bader P. Kreyenberg H. Hoelle W. Dueckers G. Handgretinger R. Lang P. Kremens B. Dilloo D. Sykora K.W. Schrappe M. Niemeyer C. Von S.A. Gruhn B. Henze G. Greil J. Niethammer D. Dietz K. Beck J.F. Klingebiel T. ( 2004) Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy Journal of Clinical Oncology, 22, 1696 1705.
4. Baron F. Baker J.E. Storb R. Gooley T.A. Sandmaier B.M. Maris M.B. Maloney D.G. Heimfeld S. Oparin D. Zellmer E. Radich J.P. Grumet F.C. Blume K.G. Chauncey T.R. Little M.T. ( 2004) Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood, 104, 2254 2262.
5. Barrett A.J. Mavroudis D. Tisdale J. Molldrem J. Clave E. Dunbar C. Cottler-Fox M. Phang S. Carter C. Okunnieff P. Young N.S. Read E.J. ( 1998) T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect. Bone Marrow Transplantation, 21, 543 551.
6. Barrios M. Jimenez-Velasco A. Roman-Gomez J. Madrigal M.E. Castillejo J.A. Torres A. Heiniger A. ( 2003) Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia. Haematologica, 88, 801 810.
7. Bertheas M.F. Maraninchi D. Lafage M. Fraisse J. Blaise D. Stoppa A.M. Michel G. Brizard C.P. Gaspard M.H. Novakovitch G. Mannoni P. Viens P. Carcassonne Y. ( 1988) Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentation. Blood, 72, 89 93.
8. Carvallo C. Geller N. Kurlander R. Srinivasan R. Mena O. Igarashi T. Griffith L.M. Linehan W.M. Childs R.W. ( 2004) Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors. Blood, 103, 1560 1563.
9. Childs R. Clave E. Contentin N. Jayasekera D. Hensel N. Leitman S. Read E.J. Carter C. Bahceci E. Young N.S. Barrett A.J. ( 1999) Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood, 94, 3234 3241.
10. Drobyski W.R. Hessner M.J. Klein J.P. Kabler-Babbitt C. Vesole D.H. Margolis D.A. Keever-Taylor C.A. ( 1999) T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation. Blood, 94, 434 441.
11. Elmaagacli A.H. Peceny R. Steckel N. Trenschel R. Ottinger H. Grosse-Wilde H. Schaefer U.W. Beelen D.W. ( 2003) Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia. Blood, 101, 446 453.
12. Lamba R. Abella E. Kukuruga D. Klein J. Savasan S. Abidi M.H. Mohamed A. Peres E. ( 2004) Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival. Leukemia, 18, 1681 1686.
13. MacKinnon S. Barnett L. Heller G. O'Reilly R.J. ( 1994) Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood, 83, 3409 3416.
14. Marmont A.M. Horowitz M.M. Gale R.P. Sobocinski K. Ash R.C. van Bekkum D.W. Champlin R.E. Dicke K.A. Goldman J.M. Good R.A. Herzig R.H. Hong R. Masaoka T. Rimm A.A. Ringden O. Speck B. Weiner R.S. Bortin M.M. ( 1991) T-cell depletion of HLA-identical transplants in leukemia. Blood, 78, 2120 2130.
15. Nollet F. Billiet J. Selleslag D. Criel A. ( 2001) Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing. Bone Marrow Transplantation, 28, 511 518.
16. Offit K. Burns J.P. Cunningham I. Jhanwar S.C. Black P. Kernan N.A. O'Reilly R.J. Chaganti R.S. ( 1990) Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation. Blood, 75, 1346 1355.
17. Petz L.D. Yam P. Wallace R.B. Stock A.D. de L.G. Knowlton R.G. Brown V.A. Donis-Keller H. Hill L.R. Forman S.J. Blume K.G. ( 1987) Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood, 70, 1331 1337.
18. Schaap N. Schattenberg A. Bar B. Preijers F. Geurts van K.A. van der M.R. de B.T. De W.T. ( 1997) Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen. British Journal of Haematology, 98, 750 759.
19. Schaap N. Schattenberg A. Mensink E. Preijers F. Hillegers M. Knops R. Pennings A. Boezeman J. Geurts van K.A. de P.B. De W.T. ( 2002) Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation. Leukemia, 16, 13 21.
20. Schattenberg A. De W.T. Salden M. Vet J. Van D.B. Smeets D. Hoogenhout J. Haanen C. ( 1989) Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse. Blood, 73, 1367 1372.
21. Sehn L.H. Alyea E.P. Weller E. Canning C. Lee S. Ritz J. Antin J.H. Soiffer R.J. ( 1999) Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion. Journal of Clinical Oncology, 17, 561 568.
22. Solomon S.R. Nakamura R. Read E.J. Leitman S.F. Carter C. Childs R. Dunbar C.E. Young N.S. Barrett A.J. ( 2003) Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation 1. Bone Marrow Transplantation, 31, 783 788.
23. Walker H. Singer C.R. Patterson J. Goldstone A.H. Prentice H.G. ( 1986) The significance of host haemopoietic cells detected by cytogenetic analysis of bone marrow from recipients of bone marrow transplants. British Journal of Haematology, 62, 385 391.